Income Statement (TTM)
PT UBC Medical Indonesia Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 12-31 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|
| Revenue | 136,699 | 147,637 | 152,358 | 169,800 |
| Change (%) | 8.00 | 3.20 | 11.45 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 82,135 | 90,882 | 94,658 | 107,235 |
| Change (%) | 10.65 | 4.16 | 13.29 | |
| % of Revenue | 60.08 | 61.56 | 62.13 | 63.15 |
| Gross Operating Profit | 54,564 | 56,755 | 57,699 | 62,564 |
| Change (%) | 4.02 | 1.66 | 8.43 | |
| % of Revenue | 39.92 | 38.44 | 37.87 | 36.85 |
| SG&A | 48,720 | 47,803 | 47,091 | 49,967 |
| Change (%) | -1.88 | -1.49 | 6.11 | |
| % of Revenue | 35.64 | 32.38 | 30.91 | 29.43 |
| R&D | ||||
| Change (%) | ||||
| % of Revenue | ||||
| OpEx | 130,856 | 138,685 | 141,749 | 157,202 |
| Change (%) | 5.98 | 2.21 | 10.90 | |
| % of Revenue | 95.73 | 93.94 | 93.04 | 92.58 |
| Operating Income | 5,844 | 8,952 | 10,608 | 12,597 |
| Change (%) | 53.19 | 18.50 | 18.75 | |
| % of Revenue | 4.27 | 6.06 | 6.96 | 7.42 |
| Interest Expense | -2,153 | -3,041 | -2,784 | -2,202 |
| Change (%) | 41.22 | -8.46 | -20.90 | |
| % of Revenue | -1.58 | -2.06 | -1.83 | -1.30 |
| Net Income | 2,190 | 2,952 | 3,873 | 8,242 |
| Change (%) | 34.84 | 31.18 | 112.81 | |
| % of Revenue | 1.60 | 2.00 | 2.54 | 4.85 |
Source: Capital IQ
